The iShares Biotechnology ETF (IBB) provides exposure to healthcare innovation with a focus on the biggest firms by market ...

Designed to provide broad exposure to the Healthcare - Biotech segment of the equity market, the Invesco Biotechnology & Genome ETF (PBE) is a passively managed exchange traded fund launched on June ...

Biotech stocks are flashing risk-on. The SPDR S&P Biotech ETF has outperformed the broader Health Care Select Sector SPDR ...

Biotech ETFs have had a banner year, earning some investors returns north of 30 percent since January. I say “some investors” because, it turns out, not all biotech ETFs are created equal. In our 2012 ...

Launched on 06/23/2005, the Invesco Biotechnology & Genome ETF (PBE) is a smart beta exchange traded fund offering broad exposure to the Health Care ETFs category of the market. What Are Smart Beta ...

Designed to provide broad exposure to the Healthcare - Biotech segment of the equity market, the First Trust NYSE Arca Biotechnology ETF (FBT) is a passively managed exchange traded fund launched on ...

iShares Biotechnology ETF (NASDAQ:IBB) - $0.0828. Payable Sep 19; for shareholders of record Sep 16; ex-div Sep 16. BBH Vs. IBB: How To Prepare For The Next Biotech Growth Cycle With BBH Biotech Looks ...

Diversify Outside the U.S. Heavyweights: Global healthcare ETFs like iShares Global Healthcare ETF (NYSE: MIXJ) provide ...

Wealth Enhancement Advisory Services LLC increased its position in shares of Invesco Biotechnology & Genome ETF (NYSEARCA:PBE – Free Report) by 10.6% during the fourth quarter, according to the ...

Bank Julius Baer & Co. Ltd Zurich lowered its position in iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 95.7% in the 1st quarter, according to its most recent disclosure with the Securities ...